Mineralys Therapeutics, Inc. – NASDAQ:MLYS
Mineralys Therapeutics stock price today
$14.47
+1.65
+12.87%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 5 hours
Mineralys Therapeutics stock price monthly change
-11.46%
month
Mineralys Therapeutics stock price quarterly change
-11.46%
quarter
Mineralys Therapeutics stock price yearly change
+53.72%
year
Mineralys Therapeutics key metrics
Market Cap | 592.74M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -2.16 |
Revenue | N/A |
EBITDA | -105.07M |
Income | -90.79M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMineralys Therapeutics stock price history
Mineralys Therapeutics stock forecast
Mineralys Therapeutics financial statements
| Jun 2023 | 0 | -12.14M | |
|---|---|---|---|
| Sep 2023 | 0 | -22.76M | |
| Dec 2023 | 0 | -24.38M | |
| Mar 2024 | 0 | -31.50M |
| 2025 | 0 | -173.20M | |
|---|---|---|---|
| 2026 | 0 | -192.04M | |
| 2027 | 78.07M | -142.46M | -182.48% |
| 2028 | 206.89M | -90.22M | -43.61% |
Analysts Price target
Financials & Ratios estimates
| 2023-11-07 | -0.72 | -0.57 |
|---|---|---|
| 2024-03-21 | -0.85 | -0.61 |
| 2024-05-09 | -0.68 | -0.7 |
| Jun 2023 | 291217000 | 6.20M | 2.13% |
|---|---|---|---|
| Sep 2023 | 277555000 | 13.54M | 4.88% |
| Dec 2023 | 251636000 | 10.48M | 4.17% |
| Mar 2024 | 347249000 | 19.20M | 5.53% |
| Jun 2023 | -20.38M | -16.13M | -581K |
|---|---|---|---|
| Sep 2023 | -19.03M | 4.00M | 184K |
| Dec 2023 | -28.98M | -8.08M | 74K |
| Mar 2024 | -19.13M | -55.95M | 116.20M |
Mineralys Therapeutics alternative data
| Sep 2023 | 12 |
|---|---|
| Oct 2023 | 12 |
| Nov 2023 | 12 |
| Dec 2023 | 12 |
| Jan 2024 | 12 |
| Feb 2024 | 12 |
| Mar 2024 | 28 |
| Apr 2024 | 28 |
| May 2024 | 28 |
| Jun 2024 | 28 |
| Jul 2024 | 28 |
Mineralys Therapeutics other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2024 | 555555 | 0 |
| May 2024 | 0 | 100 |
| Jun 2024 | 0 | 218925 |
| Jul 2024 | 0 | 577028 |
| Oct 2024 | 0 | 26028 |
| Nov 2024 | 0 | 30508 |
| Quarter | Transcript |
|---|---|
| Q1 2024 9 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 21 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 12 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 12 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of Mineralys Therapeutics stock today?
One share of Mineralys Therapeutics stock can currently be purchased for approximately $14.47.
-
When is Mineralys Therapeutics's next earnings date?
Unfortunately, Mineralys Therapeutics's (MLYS) next earnings date is currently unknown.
-
Does Mineralys Therapeutics pay dividends?
No, Mineralys Therapeutics does not pay dividends.
-
How much money does Mineralys Therapeutics make?
Mineralys Therapeutics has a market capitalization of 592.74M. Mineralys Therapeutics made a loss 71.9M US dollars in net income (profit) last year or -$0.7 on an earnings per share basis.
-
What is Mineralys Therapeutics's stock symbol?
Mineralys Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "MLYS".
-
What is Mineralys Therapeutics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Mineralys Therapeutics?
Shares of Mineralys Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Mineralys Therapeutics have?
As Jul 2024, Mineralys Therapeutics employs 28 workers.
-
When Mineralys Therapeutics went public?
Mineralys Therapeutics, Inc. is publicly traded company for more then 2 years since IPO on 10 Feb 2023.
-
What is Mineralys Therapeutics's official website?
The official website for Mineralys Therapeutics is mineralystx.com.
-
Where are Mineralys Therapeutics's headquarters?
Mineralys Therapeutics is headquartered at 150 N. Radnor Chester Rd., Radnor, PA.
-
How can i contact Mineralys Therapeutics?
Mineralys Therapeutics's mailing address is 150 N. Radnor Chester Rd., Radnor, PA and company can be reached via phone at +888 3786240.
Mineralys Therapeutics company profile:
Mineralys Therapeutics, Inc.
mineralystx.comExchange:
NASDAQ
Full time employees:
28
Industry:
Biotechnology
Sector:
Healthcare
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.
150 N. Radnor Chester Rd.
Radnor, PA 19087
Radnor, PA 19087
CIK: 0001933414
ISIN: US6031701013
CUSIP: 603170101
